| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |